SE7706181L - Nya substituerade pyridiner, deras framstellning och farmaceutiska anvendning - Google Patents

Nya substituerade pyridiner, deras framstellning och farmaceutiska anvendning

Info

Publication number
SE7706181L
SE7706181L SE7706181A SE7706181A SE7706181L SE 7706181 L SE7706181 L SE 7706181L SE 7706181 A SE7706181 A SE 7706181A SE 7706181 A SE7706181 A SE 7706181A SE 7706181 L SE7706181 L SE 7706181L
Authority
SE
Sweden
Prior art keywords
manufacture
pharmaceutical use
substituted pyridines
new substituted
new
Prior art date
Application number
SE7706181A
Other languages
English (en)
Other versions
SE428684B (sv
Inventor
J J Baldwin
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SE7706181L publication Critical patent/SE7706181L/sv
Publication of SE428684B publication Critical patent/SE428684B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7706181A 1976-06-15 1977-05-26 Analogiforfarande for framstellning av substituerade (3-lagalkylamino-2-hydroxi-propoxi)pyridiner SE428684B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/696,237 US4060601A (en) 1976-06-15 1976-06-15 Certain lower-alkyl amino-2'-hydroxy-propoxy pyridines

Publications (2)

Publication Number Publication Date
SE7706181L true SE7706181L (sv) 1977-12-16
SE428684B SE428684B (sv) 1983-07-18

Family

ID=24796255

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7706181A SE428684B (sv) 1976-06-15 1977-05-26 Analogiforfarande for framstellning av substituerade (3-lagalkylamino-2-hydroxi-propoxi)pyridiner

Country Status (9)

Country Link
US (2) US4060601A (sv)
JP (1) JPS52153971A (sv)
CH (1) CH632495A5 (sv)
DE (1) DE2726796A1 (sv)
DK (1) DK236377A (sv)
FR (1) FR2361370A1 (sv)
GB (1) GB1549132A (sv)
NL (1) NL7705881A (sv)
SE (1) SE428684B (sv)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195090A (en) * 1973-02-20 1980-03-25 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)pyridine derivatives and pharmaceutical compositions therewith
US4410530A (en) * 1973-02-20 1983-10-18 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)-mono-and diazines
US4000282A (en) * 1974-12-16 1976-12-28 Merck & Co., Inc. 2-(3-tert. butyl or isopropylamino-2-hydroxypropoxy)-3-cyanopyridines
US4091104A (en) * 1976-06-15 1978-05-23 Merck & Co., Inc. Substituted (3-loweralkylamino-2-R1 O-propoxy)pyridines, their preparation and use
US4053605A (en) * 1976-06-15 1977-10-11 Merck & Co., Inc. Esterified-2(3-lower-alkyl-amino-propoxy)-3-cyano-pyridines and derivatives
DE2711655A1 (de) * 1977-03-17 1978-09-21 Basf Ag Pyridinyl-aminoalkylaether
US4279913A (en) * 1978-01-04 1981-07-21 Merck & Co., Inc. Polysubstituted-2-(3-loweralkylamino-2-R1 O-propoxy)pyridines
US4144343A (en) * 1978-01-04 1979-03-13 Merck & Co., Inc. Heterocycle substituted (3-loweralkylamino-2-R1 O-propoxy)pyridines
JPS54106476A (en) * 1978-01-04 1979-08-21 Merck & Co Inc Multiisubstituted 22*33lower alkylaminoo22 r100propoxy*pyridine
US4393212A (en) * 1979-01-29 1983-07-12 Merck & Co., Inc. Certain nicotinic acid esters and corresponding nicotinonitriles
US4234590A (en) * 1979-02-05 1980-11-18 Merck & Co., Inc. Thiosubstituted pyridines
US4259327A (en) * 1979-04-02 1981-03-31 Merck & Co., Inc. Substituted aminoalkoxypyridines, compositions and use thereof
US4330546A (en) * 1979-09-14 1982-05-18 John Wyeth & Brother Limited 3-Aryl-3-aryloxypropylamines
US4329351A (en) * 1979-10-01 1982-05-11 Merck & Co., Inc. 2-Substituted propoxy-3-cyano-5-RO-pyridines and intermediates
JPS5798262A (en) * 1980-12-10 1982-06-18 Yoshitomi Pharmaceut Ind Ltd Pyridine derivative
ES8503657A1 (es) * 1983-07-06 1985-04-01 Fabr Prod Quimicos Y Farmaceut Un procedimiento para la preparacion de derivados de 3-sulfonamidopiridinas 2 -sustituidas.

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA737907A (en) 1966-07-05 Karl Pfister, Iii Antihypertensive composition
US3459782A (en) * 1963-08-26 1969-08-05 Boehringer Sohn Ingelheim 1-substituted phenoxy-2-hydroxy-3-isopropylamino-propanes
DE1617336C2 (de) 1966-11-25 1982-07-01 C.H. Boehringer Sohn, 6507 Ingelheim Arzneimittel gegen Angina pectoris
DE1593783A1 (de) 1966-12-30 1972-05-25 Boehringer Sohn Ingelheim Verfahren zur Herstellung von 1-(2-Nitrilophenoxy)-2-hydroxy-3-isopropylaminopropan und dessen Salzen
FR1576539A (sv) * 1968-05-21 1969-08-01
NL6907700A (sv) 1968-05-22 1969-11-25
DE1919342A1 (de) 1969-04-16 1970-12-03 Boehringer Sohn Ingelheim Herzwirksame Kombinationspraeparate
US3655663A (en) * 1969-04-21 1972-04-11 Burton K Wasson 4-(3-secondary amino-2-hydroxy-proxy) 1 2 5-thiadiazoles
SE343478B (sv) 1970-07-15 1972-03-13 F Linder
US3946009A (en) * 1972-05-05 1976-03-23 Merck Sharp & Dohme (I.A.) Corporation 2-(3-Substituted amino-2-hydroxypropoxy)-3-substituted pyrazines
CA1001631A (en) * 1972-05-05 1976-12-14 Merck Sharp And Dohme (I.A.) Corp. 2-(3-substituted amino-2-hydroxy-propoxy)-3-substituted pyrazines and method for preparation
LU65414A1 (sv) * 1972-05-24 1973-12-04
AR208397A1 (es) * 1973-02-20 1976-12-27 Ciba Geigy Ag Procedimiento para la elaboracion de compuestos de 1-piridiloxi-2-hidroxi-3-amino-propano1-piraziniloxi-2-hidroxi-3-amino-propano y 1-pirimidiniloxi-2-hidroxi-3-amino-propan
LU69043A1 (sv) * 1973-12-20 1975-08-20
DE2507902A1 (de) * 1974-04-02 1975-10-09 Ciba Geigy Ag Neue amine und verfahren zu ihrer herstellung
US4000282A (en) * 1974-12-16 1976-12-28 Merck & Co., Inc. 2-(3-tert. butyl or isopropylamino-2-hydroxypropoxy)-3-cyanopyridines
GB1485919A (en) * 1975-08-12 1977-09-14 Grindstedvaerket As Pyridine derivatives

Also Published As

Publication number Publication date
JPS52153971A (en) 1977-12-21
JPS6341904B2 (sv) 1988-08-19
NL7705881A (nl) 1977-12-19
SE428684B (sv) 1983-07-18
DE2726796A1 (de) 1977-12-29
CH632495A5 (de) 1982-10-15
DK236377A (da) 1977-12-16
FR2361370B1 (sv) 1979-10-12
US4125618A (en) 1978-11-14
GB1549132A (en) 1979-08-01
FR2361370A1 (fr) 1978-03-10
US4060601A (en) 1977-11-29

Similar Documents

Publication Publication Date Title
FI771951A7 (fi) Nya halosporinderivat
FI772823A7 (fi) Nya 1-aryloxi-hydroxi-3-alkylenaminopropaner och foerfarande foer deras framstaellning
SE7614085L (sv) Nya organiska foreningar, deras framstellning och anvendning
SE7608748L (sv) Acyl-sackariner och acyl-3-oxo-1,2-bensisotiazoliner
FI773804A7 (fi) Nya nukleosider och foerfarande foer deras framstaellning
SE7706181L (sv) Nya substituerade pyridiner, deras framstellning och farmaceutiska anvendning
FI772262A7 (fi) Nya fenyletylaminer och foerfarande foer deras framstaellning
FI772594A7 (fi) Nya uracilfoereningar och foerfarande foer deras framstaellning
SE7706182L (sv) Substituerade (3-lagalkylamino-2-r,10-propoxi)pyridiner, deras framstellning och anvendning
SE7800633L (sv) Nya organiska foreningar, deras framstellning och anvendning
SE7701155L (sv) Nya organiska foreningar, deras framstellning och anvendning
SE7700606L (sv) Nya organiska foreningag deras anvendning och framstellning
SE7706059L (sv) Nya 1-aryloxi-2-hydroxi-3-aminopropaner och forfarande for deras framstellning
SE7606877L (sv) Nya organiska foreningar, deras framstellning och anvendning
SE7800452L (sv) Nya organiska foreningar, deras framstellning och anvendning
SE7613948L (sv) Nya pyrrolidoner och forfarande for deras framstellning
SE7710993L (sv) Nya pyridobensodiazepiner, forfarande for framstellning derav och lekemedel innehallande dessa
SE7710504L (sv) Nya heterocykliska foreningar, deras anvendning och framstellning
SE7713243L (sv) Substituerade aminoetanoler, deras framstellning och farmaceutiska anvendning
SE7607729L (sv) Nya morfolinderivat och framstellning derav
SE7506758L (sv) Nya heterocykliska foreningar, deras framstellning och anvendning.
SE7606405L (sv) Nya organiska foreningar, deras framstellning och anvendning
FI772261A7 (fi) Nya aryl-alkylaminer och deras framstaellningsfoerfarande
SE7803040L (sv) Nya organiska foreningar, deras framstellning och anvendning
SE7807996L (sv) Pyridinderivat, deras framstellning och anvendning